A great way to boost your portfolio's growth is to get in on companies during the early stages of their growth stories. And one that fits the bill right now is CRISPR Therapeutics (NASDAQ: CRSP). The biotech company recently won approval for its first product -- one that shows the strength of its gene editing technology and could potentially bring in billions of dollars in revenue.

You won't need a fortune to invest in CRISPR Therapeutics, trading for about $60 a share. But if you have $1,000, you can pick up a solid handful of shares and possibly set yourself up for a big win down the road as the company progresses along the path of earnings growth and additional product approvals. Let's find out more about this ultimate growth stock to pick up right now.

Image source: Getty Images.

Continue reading

Source Fool.com